Skip to main content

Research Repository

Advanced Search

PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis

Midgley, Angela; Barakat, Dina; Braitch, Manjit; Nichols, Calen; Nebozhyn, Mihailo; Edwards, Laura J.; Fox, Susan C.; Gran, Bruno; Robins, R. Adrian; Showe, Louise C.; Constantinescu, Cris S.

PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis Thumbnail


Authors

Angela Midgley

Dina Barakat

Manjit Braitch

Calen Nichols

Mihailo Nebozhyn

LAURA EDWARDS Laura.Edwards@nottingham.ac.uk
Clinical Associate Professor

Susan C. Fox

Bruno Gran

R. Adrian Robins

Louise C. Showe

Cris S. Constantinescu



Abstract

© 2020 Elsevier GmbH IL-23 is a potent stimulus for Th17 cells. These cells have a distinct developmental pathway from Th1 cells induced by IL-12 and are implicated in autoimmune and inflammatory disorders including multiple sclerosis (MS). TGF-β, IL-6, and IL-1, the transcriptional regulator RORγt (RORC) and IL-23 are implicated in Th17 development and maintenance. In human polyclonally activated T cells, IL-23 enhances IL-17 production. The aims of our study were: 1). To validate microarray results showing preferential expression of platelet activating factor receptor (PAF-R) on IL-23 stimulated T cells. 2). To determine whether PAF-R on activated T cells is functional, whether it is co-regulated with Th17-associated molecules, and whether it is implicated in Th17 function. 3). To determine PAF-R expression in MS. We show that PAF-R is expressed on activated T cells, and is inducible by IL-23 and IL-17, which in turn are induced by PAF binding to PAF-R. PAF-R is co-expressed with IL-17 and regulated similarly with Th17 markers IL-17A, IL-17F, IL-22 and RORC. PAF-R is upregulated on PBMC and T cells of MS patients, and levels correlate with IL-17 and with MS disability scores. Our results show that PAF-R on T cells is associated with the Th17 phenotype and function. Clinical Implications Targeting PAF-R may interfere with Th17 function and offer therapeutic intervention in Th17-associated conditions, including MS.

Citation

Midgley, A., Barakat, D., Braitch, M., Nichols, C., Nebozhyn, M., Edwards, L. J., …Constantinescu, C. S. (2021). PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis. Immunobiology, 226(1), Article 152023. https://doi.org/10.1016/j.imbio.2020.152023

Journal Article Type Article
Acceptance Date Oct 18, 2020
Online Publication Date Dec 3, 2020
Publication Date Jan 1, 2021
Deposit Date Dec 10, 2020
Publicly Available Date Dec 4, 2021
Journal Immunobiology
Print ISSN 0171-2985
Electronic ISSN 1878-3279
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 226
Issue 1
Article Number 152023
DOI https://doi.org/10.1016/j.imbio.2020.152023
Keywords Immunology; Immunology and Allergy; Hematology
Public URL https://nottingham-repository.worktribe.com/output/5131153
Publisher URL https://www.sciencedirect.com/science/article/pii/S0171298520305453
Additional Information This article is maintained by: Elsevier; Article Title: PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis; Journal Title: Immunobiology; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.imbio.2020.152023; Content Type: article; Copyright: © 2020 Elsevier GmbH. All rights reserved.

Files





You might also like



Downloadable Citations